Published ahead of print on December 10, 2004, doi:10.1164/rccm.200408-1088OC
American Journal of Respiratory and Critical Care Medicine Vol 171. pp. 587-590, (2005)
© 2005 American Thoracic Society
doi: 10.1164/rccm.200408-1088OC
Fluticasone Improves Pulmonary Function in Children under 2 Years Old with Risk Factors for Asthma
Alejandro M. Teper,
Carlos D. Kofman,
Gabriela A. Szulman,
Santiago M. Vidaurreta and
Alberto F. Maffey
Respiratory Center, "Ricardo Gutierrez" Children's Hospital, Buenos Aires, Argentina
Correspondence and requests for reprints should be addressed to Alejandro M. Teper, M.D., Respiratory Center, Hospital de Niños Ricardo Gutiérrez, Gallo 1330, Buenos Aires, Argentina. E-mail: ateper{at}intramed.net
This study assessed the effects of treatment with fluticasone in children younger than 2 years old with recurrent wheezing and risk factors of developing asthma. This double-blind placebo-controlled study randomized children to receive fluticasone (125 µg; n = 14) or placebo (n = 12) twice daily for 6 months. Pulmonary function was assessed at the beginning and end, and parents filled out a daily diary recording respiratory symptoms, need for rescue medication, and emergency care. The SD score of maximum flow at functional residual capacity was –0.74 ± 0.6 at the beginning and 0.44 ± 1 at the end for the fluticasone group (p = 0.001), and –0.79 ± 0.3 at the beginning and –0.78 ± 1.4 at the end for the placebo group (p = 0.97). A statistically significant difference (p = 0.02) was observed between treatments. The percentage of symptom-free days was 91.3 ± 7% for fluticasone and 83.9 ± 10% for placebo (p = 0.05). The number of respiratory exacerbations was 2.1 ± 1.7 and 4.1 ± 3 (p = 0.04), and the percentage of days on albuterol was 8.6 ± 6% and 16.3 ± 9% (p = 0.028). Treatment with fluticasone twice daily for 6 months improves pulmonary function and clinical outcomes in children with asthma younger than 2 years.
Key Words: asthma • infants • inhaled corticosteroids • pulmonary function
This article has been cited by other articles:
|
|
|
|
 
P. L. P. Brand, E. Baraldi, H. Bisgaard, A. L. Boner, J. A. Castro-Rodriguez, A. Custovic, J. de Blic, J. C. de Jongste, E. Eber, M. L. Everard, et al.
Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach
Eur. Respir. J.,
October 1, 2008;
32(4):
1096 - 1110.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Eigen
Differential Diagnosis and Treatment of Wheezing and Asthma in Young Children
Clinical Pediatrics,
October 1, 2008;
47(8):
735 - 743.
[PDF]
|
|
|
|
|
|
|
M. J. Welch
Nebulization Therapy for Asthma: A Practical Guide for the Busy Pediatrician
Clinical Pediatrics,
October 1, 2008;
47(8):
744 - 756.
[PDF]
|
|
|
|
|
|
|
J H Baumer
Recent asthma updates in the USA and UK
Arch. Dis. Child. Ed. Pract.,
April 1, 2008;
93(2):
66 - 68.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. C. Moore and S. P. Peters
Update in Asthma 2006
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
649 - 654.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Wenzel and R. Covar
Update in asthma 2005.
Am. J. Respir. Crit. Care Med.,
April 1, 2006;
173(7):
698 - 706.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. P. Galant, T. Morphew, S. Amaro, and O. Liao
Current Asthma Guidelines May Not Identify Young Children Who Have Experienced Significant Morbidity
Pediatrics,
April 1, 2006;
117(4):
1038 - 1045.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. J. F. M. Merkus and J. C. de Jongste
Inhaled Corticosteroids in Wheezy Infants
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
1058 - 1059.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Teper, C. D. Kofman, and S. M. Vidaurreta
Inhaled Corticosteroids in Wheezy Infants
Am. J. Respir. Crit. Care Med.,
October 15, 2005;
172(8):
1059 - 1059.
[Full Text]
[PDF]
|
|
|
Copyright © 2005 American Thoracic Society
|
|
|
